An oligosaccharide of the O-linked type distinguishes the free from the combined form of hCG [alpha] subunit by Cole, Laurence A. et al.
Vol. 122, No. 3, 1984 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
August 16, 1984 Pages 1260-1267 
AN OLIGOSACCHARIDE OF THE O-LINKED TYPE DISTINGUISHES 
THE FREE FROM THE COMBINED FORM OF hCG c1 SUBUNIT 
Laurence A. Cole*, Fulvio Perini*, 
Steven Birken+ and Raymond W. Ruddon* 
Departments of Internal Medicine and Pharmacology*, 
University of Michigan Medical School, Ann Arbor, MI 48109 
Department of Medicine+, College of Physicians and Surgeons 
of Columbia University, New York, NY 10032 
Received June 22, 1984 
SUMMARY: JAR malignant trophoblast cells produce a free c( subunit in addition 
to an cc combined with B subunit as hCG. The free a is larger by gel chroma- 
tography and SDS-PAGE than combined c1 and is unable to associate with B sub- 
unit to form hCG. A tryptic fragment, representing amino acid residues 36-42, 
derived from free u was larger than the corresponding fragment from combined 
CY. After neuraminidase treatment, the fragment from free CY bound peanut lectin 
aqarose, which is specific for GalBl-3GalNAc as found in O-linked oliqo- 
saccharides. The fragment also contained Gal and GalNAc (and a lesser amount 
of G~cNAc) as determined by qlycosidase sensitivity and amino sugar analyses. 
Removal of this tryptic fragment ablated the size difference between free and 
combined a subunits. 
INTRODUCTION: hCG is a qlycoprotein hormone composed of two dissimilar sub- 
units, cx and B, joined non-covalently. hCGa' contains two N-linked oliqo- 
saccharides, while hCGB contains four O-linked in addition to two N-linked 
oligosaccharides. The hCG dimer is produced by the trophoblast in pregnancy 
and by trophoblastic neoplasms (1). In addition to aB dimer, these cells 
secrete free CL and free B (l-3). Whereas the free 8 secreted by JAR 
trophoblastic cells is similar in size to B contained in dimer (M 
r 
= 36,000) 
and associates with hCGcc to form hCG (2), the free a (Mr = 24,000) is larger 
than combined rr. (M 
r 
= 22,000) and is unable to associate with hCGB to form 
hCG (1,2,4). Thus, free n may have a regulatory role in dimer formation. 
Here we compare the two forms of n subunit and show that one tryptic peptide 
of the free form contains an O-linked type of oliqosaccharide that accounts 
for the size difference between the free and combined forms. 
'Abbreviations: hCG-n, CL component of hCG; free a, free a-subunit; hCG8, B 
component of hCG; free 8, free B subunit; PNA-aqarose, peanut aqqlutinin 
linked to aqarose; M , relative molecular mass as determined by SDS 
polyacrylamide gel elec%rophoresis; PBS, phosphate buffered saline, pH 7.5; 
RIA. radioimmunoassay; DPCC, diphenylcarbamyl chloride; GalNAc, N-acetyl- 
galactosamine; GalNAc-ol, N-acetylgalactosaminitol; GlcNAc, N-acetyl- 
glucosamine; GalN, galactosamine; GlcN, glucosamine. 
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MATERIALS AND METHODS: Highly purified standard hCG2 and hCG\i (batch CR113) 
were kindly provided by the Hormone Distribution Program, NIADDKD. Asialo 
hCGB tryptic COOH-terminal peptide fragments were prepared as previously 
described (5). RIAs of standard hCG preparations and hCGfi tryptic peptide 
fragments, gel filtration on Bio-Gel PlOO, and amino acid and amino sugar 
analyses were all carried out as previously described (4-8). 
Samples containing 1 mg protein in 1 ml PBS were digested with 10 ~11 DPCC 
treated trypsin (Sigma; 3 mg/ml in 0.001 M HCl) for 2 hr at 25OC. Reactions 
were terminated by heating 3 min at 1OOOC. For neuraminidase and 
l3-galactosidase digestions, pH was adjusted to 5.0 by the addition of sodium 
citrate, Neuraminidase digestions were carried out as previously described 
(7). Digestions with bovine testis fi-galactosidase (gift from Dr. I. 
Goldstein of The University of Michigan) were carried out for 24 hr at 37°C. 
One unit of enzyme was added to start reactions and a second unit was added at 
12 hr. Gel filtration on a 1 x 110 cm column of Bio-Gel P4 (200-400 mesh) was 
carried out in 0.1 M NH4HC0 , 
Jr 
pH 7.8. Samples, 1 ml, plus markers (0.25 
mq Vitamin B and 0.1 mg yr) were applied to the columns, which were 
eluted at a rJt?e of 4 ml/hr; 1 ml fractions were collected. 
PNA-agarose lectin affinity chromatography was carried out as follows: 
Samples (1 ml) were applied to 0.7 x 25 cm columns, which were equilibrated 
with PBS. The columns were first washed with 12 ml PBS, and then with 30 ml 
PBS containing 0.2 M lactose (15 ml/hr, 2 ml fractions collected). 
JAR malignant trophoblast cells were maintained in culture as previously 
described (4). JAR cells (70% confluent in 150 cm2 flasks) were cultured 20 
i; in F;;z,e me;l~;l;;;tainainndg lOeither 'k dialyzed3fetal bovine ser3um and a mixture 
[ H]Man or [ H]GlcN; total 
radioactivity 5 mCi/flask (2). Radioactive free il and hCGn were purified from 
the media by methods similar to those previously described (2). Briefly, hCGli 
antiserum linked to Sepharose was used to extract hCG dimer + free i' from the 
media. After repeating this adsorption step to insure complete removal of 
dimer, free CY was extracted by adsorption with hCGcl antiserum linked to 
Sepharose. Bound components were eluted with guanidine hydrochloride, 
desalted and lyophilized. Free (1 preparations were taken up in PBS and 
further purified by gel filtration on Bio-Gel PlOO. Free lx eluted as a single 
peak prior to the position of standard hCGn. Aliquots of free n preparations 
migrated as single bands on SDS polyacrylamide gels (M = 24,000). hCG + 
free 13 preparations were taken up in 1 ml of 4 M guanid?ne hydrochloride, pH 
4; dimer was dissociated by incubation for 30 min at 37"C, and then subunits 
were separated by gel filtration on Bio-Gel PlOO. The hCG,x components eluted 
as a single peak in the position of standard hCGrv. Aliquots of ~~CGI 
preparations migrated as single bands on SDS polyacrylamide gels (M = 
22,000). As a carrier protein, myoqlobin, 1 mg/ml, was added to free firand 
hCGrr preparations. 
RESULTS AND DISCUSSION: As previously reported, PNA specifically binds asialo 
O-linked oligosaccharides of the structure GalBl-3GalNAc (9) and binds asialo 
hCG through such O-linked oliqosaccharides on the fi subunit (5). As indicated 
in Table 1, PNA-agarose binds neuraminidase digested standard hCGS and JAR 
hCGfi but not the subunits also treated with 6'-galactosidase, which cleaves the 
lectin determinant. Binding to PNA-agarose was the first indicator that JAR 
free 11, but not hCGn, contains an O-linked oligosaccharide. Neuraminidase 
treated hCGcl from JAR cells was unbound on PNA-aqarose, but 753 of the 
similarly treated free CL preparation was retarded (eluted with column buffer 
later than the unbound component) by PNA-agarose. The interaction of free ix 
with PNA-agarose was ablated by ti-qalactosidase treatment. That free 1. was 
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Table 1. PNA-aqarose affinity chromatography a 
Substrate 
Standard hCG preparations 











hCGA, also E-galactosidase digested 
hCGn 
Neuraminidase digested standard hCG(I tryptic 
COOH-terminal peptide fragments 
134-145 with 1 O-linked oligosaccharide 
123-133 with 2 O-linked oligosaccharides 
123-145 with 3 O-linked oligosaccharides 
133-145 synthetic pentadecapeptide 
Neuraminidase digested JAR biosynthetically- 
labeled preparations 
hCGe 




free (I, column equilibrated with 0.2 M lactose 
free n, also B-qalactosidase digested 
Neuraminidase digested JAR a-subunit tryptic 
peptides (from Fig. 1B) 
hCGu pool 1 
1 
3 
free 0 pool 1 
2 
3' 



























aStandard hCG and hCGF tryptic peptide preparations were made as described in 
“Materials and Methods". JAR biosynthetically-labeled n-subunit tryptic fragments were 
separated on Bio-Gel P4 as shown in Fig. 1B. Pools were lyophilized then taken up in 
0.1 M sodium acetate buffer, pH 5, and neuraminidase digested. Samples were applied to 
PNA-aqarose columns, eluted and fractions collected as described in "Materials and 
Methods". Fractions containing standard hCG preparations and hCGB tryptic peptides were 
quantitated by RIAs, and those containing JAR preparations by their radioactivity. The 
percent unbound is that component in the void volume, the percent retarded is that 
component eluted with PBS somewhat later than the void volume (2-6 column volumes) and 
the percent bound is that component only eluted with 0.2 M lactose. 
retarded rather than bound (i.e., eluted with a specific inhibitor) by the 
lectin suggested a weak interaction. 
We examined the known amino acid sequence of standard hCGcr (1) for a 
potential site of 0-qlycosylation (Thr or Ser, commonly with at least one 
adjacent prolyl residue, 10). Such a site is the peptide Ala-Tyr-Pro-Thr- 
Pro-Leu-Arg (residues 36-42). As reported (ll), this peptide is one of the 
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0.06 - 
, 
g 0.04- residues residues 
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FRACTION NUMBER 
3 
Fig. 1. Gel fi 
1 
tration on Bio-Gel P4 of tryptic digests of standard hCGa and 
JAR [ H]Leu/Pro/GlcN biosynthetically-labeled a-subunit prepara- 
tions. Panel A shows the tryptic digest of 2 mg standard hCGa. 
Fractions containing peptides with aromatic amino acids were moni- 
tored by their absorbance at 280 nm, other fractions by amino acid 
dL3lySeS. Panel B shows JAR biosynthetically-labeled hCGa CM] 
and free a (0 -----0) tryptic digests. Samples were applied to 
columns together with elution markers, 
"=tamln 
and Tyr. In 
81Zy their eluate fractions tryptic peptides were identified radio- 
activity and elution markers (arrows) by their absorbance at 280 nm. 
As illustrated, pools were prepared of the peak fractions of hCGu 
peptides (1, 2 and 3) and free a peptides (1, 2 and 3') for further 
studies. Panel C shows neuraminidase treated JAR biosynthetically- 
labeled hCGcl (-1 and free a (O-----O) tryptic digests. 
products of trypsin treatment of unreduced standard hCGa. We used Bio-Gel P4 
to separate and compare the tryptic fragments of unreduced standard hCGa and 
unreduced biosynthetically-labeled JAR hCGcx and free E (Fig. 1). By 
absorbance at 280 nm, two peaks of standard hCGa fragments were detected, in 
the void volume and in tube 59. Determination of the Leu/Pro ratio by amino 
acid analysis was used to identify the disulfide cross-linked core and the 
peptides 36-42 and 46-51. JAR hCGcl tryptic fragments eluted in the same 
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volumes as standard hCGcl fragments, strongly suggesting that the compositions 
of the two JAR peptides corresponded to those of standard hCGcc. One free c1 
tryptic fragment eluted in the position of the disulfide cross-linked core, a 
second in the position of peptide 46-51, but no radioactivity was found in the 
position of peptide 36-42. Instead, two small peaks corresponding to peptides 
of larger molecular size were observed (Fig. 1B). As expected, treatment with 
neuraminidase failed to shift the elution positions of the hCGcx fragments 
(N-linked oligosaccharides are in the disulfide cross-linked core, 11). In 
contrast, treatment of the free c( tryptic digest with neuraminidase shifted 
the elution position of the two small peaks, with the appearance of an 
incompletely resolved peak to the left of peptide 46-51 (Fig. 1C) . With 
B-galactosidase treatment the elution position of the incompletely resolved 
peak was shifted to a position between peptide 46-51 and hCGcc peptide 36-42 
(not shown). This indicated the presence of NeuAc and BGal on the tryptic 
peptide derived from free c(. To further examine this peptide and to determine 
if it is responsible for the free n:PNA-agarose interaction (Table l), pools 
were prepared from the Bio-Gel P4 peaks of JAR free u and hCGcl tryptic fraq- 
ments (Fig. 1). The pools were lyophilized, taken up in 0.1 M sodium acetate, 
PR 5, neuraminidase treated then applied to PNA-agarose. The neuraminidase 
treated free ry pool 3' (the unique qlycosidase-sensitive peaks) was the only 
component bound by PNA-aqarose (Table 1). The treated pool 3' was bound 
rather than retarded by the lectin, similar to treated hCGB tryptic qlyco- 
peptides containing 1, 2, or 3 O-linked oliqosaccharides. That the free a 
glycoprotein is retarded by PNA-aqarose but its tryptic fragment containing 
the carbohydrate determinant is bound suggests that the presence of the 
disulfide cross-linked core sterically hinders or lessens the affinity of the 
determinant for the lectin. 
The PNA-aqarose affinity chromatography suggested an oliqosaccharide on 
free a of the structure Galel-3GalNAc. Sensitivity to neuraminidase and 
B-galactosidase showed that the structure is sialylated and contains fiGal. To 
confirm the presence of GalNAc on free a pool 3' and to show that pool 3' was 
in fact a qlycosylated form of the absent peak, 36-42 (Fig. lB), amino acid 
analyses were carried out on the labeled pools (Table 2). Free a pool 3' and 
hCGcl pool 3 (residues 36-42) contained the same ratio of Leu to Pro residues 
(1:1.9). This is the expected Leu to Pro ratio for standard hCGcc residue 
36-42 (1:2). No amino sugars were detected on the hCGcx tryptic fragment; 
however, free 0. pool 3' contained labeled GalN (acid hydrolysis product of 
GalNAc) and lesser amounts of labeled GlcN (acid hydrolysis product of 
GlcNAc). Our results clearly suggest that free CL peptide 36-42, unlike the 
corresponding hCGcl peptide, contains an oligosaccharide of the composition 
NeuAc, @Gal, GalNAc probably arranged as are the O-linked tetrasaccharides on 
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Table 2. Amino acid analysesa of JAR [ 
3 H]Pro/Leu/GlcN-labeled hCGa and free r~ 
SXllple Leu:Pro ratio Leu:GlcN ratio Leu:GalN ratio 
hCG\r pool 3 (residues 36-42) 
free :* pool 3' 
1:1.9 1:o I:0 
1:1.9 1:0.39 1:0.71 
a 
Pools of JAR free rl and hCGu tryptic fragments separated on Bio-Gel P4 (Fig. 1B) 
were made. The pools, and JAR free CI, hCGa and hCGr preparations were lyophrllzed then 
acid hydrolyzed and subJected to amino acid analyses. The relative cpm/residue was 
determined, assuming 4 Leu, 7 Pro and 8 GlcNAc residues on hCGcl or free II, and 4 GalNAc 
residues on hCGe isolated from the same media preparation (1). Values are the ratlo of 
Leu resrdues to pro, GlcN and GalN (hydrolyzed GlcNAc and GalNAc) residues. 
hCGB (1) containing the PNA-agarose determinant, NeuAc-GalBl-3 (NeuAc-)GalNAc- 
o-. 
Peptide 36-42 contains a site for 0-qlycosylation, Thr 39. As recently 
reported (4), a portion of JAR hCGC O-linked oliqosaccharides also contain 
GlcNAc, seemingly as part of more complex structures of the same size as those 
found on fetuin, NeuAc-GalBl-3(NeuAc-GalBl-4GlcNAcfi-)GalNAc-0-. Our finding 
of a small amount of GlcN in free CI pool 3' (Table 2) suggests that a portion 
of free c( 36-42 peptides may also contain this larger alternative oliqo- 
saccharide. A larger GlcNAc-containing O-linked oliqosaccharide and an 
hCGli-like O-linked oliqosaccharide as alternative structures on free t~ 36-42 
could explain the finding of two peaks for this peptide in the eluate of 
Bio-Gel P4 (Fig. 1B). Several attempts were made to B-eliminate free u or its 
tryptic peptides and so release the oligosaccharide in question (4). LOW 
yields were always obtained (about 40% GalNAc converted to GalNAc-01) for the 
P-elimination of intact free U, although under the same conditions the 
B-elimination of hCGB and of the incorporated standard ovine submaxillary 
mucin was complete (Peters, B.P. and Ruddon, R.W., unpublished observations), 
suggesting that steric factors block E-elimination of free II. Corless and 
Boime (Personal Communication) have recently found that the peptide backbone 
of the analogous tryptic fragment from the large free rx of LH in bovine 
pituitary is unstable to alkaline borohydride. This could expose a free 
carboxyl terminal on the Thr attachment site of the oliqosaccharide rendering 
it resistant to B-elimination (12). We are further investigating the 
B-elimination of free OL, which will be the sublect of a future communication. 
We used gel filtration to determine if the O-linked oliqosaccharide 
accounts for the size difference of free u and hCGn. Intact and trypsin 
digested free (1 and hCGa were chromatographed on Bio-Gel PlOO (Fig. 2). 
Whereas free c( eluted somewhat prior to hCGu, the disulfide cross-linked cores 
of both forms of a subunit co-eluted on Bio-Gel PlOO. This indicates that 
removal of peptide 36-42 containing the O-linked oliqosaccharide ablates the 
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200 
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FRACTION NUMBER 
Fig. 2. Gel filtration on Bio-Gel ~100 of JAR [U~]~eu/~r~/~an 
biosynthetically-labeled hCGcl and free a, and their disulfide 
cross-linked core tryptic fragments. Panel A, JAR hCGa (m) and 
free :I (@---o). Panel B, tryptic digest of JAR hCGa (u) and 
free a (G---O); small peptides, residues 36-42 and 46-51 eluted in 
total volume (fraction 167, not shown). Arrows indicate the void 
volume and the elution positions of standard hCG, hCGa and hCG6. 
free c1 vs. hCGa size difference (the third tryptic component, peptide 46-51, 
from free u co-eluted with that from hCGcc on Bio-Gel P4, Fig. 1). 
Our results using gel filtration, sizing of tryptic fragments, PNA- 
agarose affinity chromatography, 8-elimination, and amino acid analysis 
indicate that an O-linked type of oliqosaccharide, probably attached to Thr 
39, predominantly accounts for the size difference between free IY. and hCGa. 
Free c( is unable to combine with hCGn to form hCG (2). Parsons and Pierce 
(13) have examined the bovine pituitary free a and identified an O-linked 
oliqosaccharide on Thr 43 (corresponds to hCGo Thr 39). They showed that 
bovine pituitary free ci, which does not combine with bLH B-subunit, combined 
following the removal of the O-linked oligosaccharide. It seems likely 
therefore that the O-linked sugars on human trophoblast free w. also block 
combination. Our future studies aim to examine 0-qlycosylation of c1 subunit 
and its possible role in regulating subunit combination and secretion. 
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